Gallant is developing FDA-regulated, off-the-shelf mesenchymal stromal cell therapies to rapidly modulate inflammation, support tissue repair, and make stem cell treatment broadly available to cats ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback